2.27
前日終値:
$2.28
開ける:
$2.26
24時間の取引高:
77,865
Relative Volume:
0.35
時価総額:
$68.64M
収益:
$193.67M
当期純損益:
$4.82M
株価収益率:
16.18
EPS:
0.1403
ネットキャッシュフロー:
$15.53M
1週間 パフォーマンス:
-5.02%
1か月 パフォーマンス:
-4.22%
6か月 パフォーマンス:
-71.16%
1年 パフォーマンス:
-77.30%
Zynex Inc Stock (ZYXI) Company Profile
ZYXI を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
9.30 | 0 | 0 | 0 | 0 | 0.00 | |
![]()
MOBBW
Mobilicom Limited Warrants
|
0.4126 | 597.27M | 0 | 0 | 0 | 0.00 |
![]()
GOODO
Gladstone Commercial Corporation
|
20.25 | 372.90M | 0 | 0 | 0 | 0.00 |
![]()
SHMD
Schmid Group N V
|
3.08 | 128.33M | 0 | 0 | 0 | 0.00 |
![]()
PSNYW
Polestar Automotive Holding Uk
|
0.1602 | 360.17M | 2.07B | -1.42B | -1.37B | -0.6765 |
![]()
DAVEW
Dave Inc
|
1.18 | 0 | 0 | 0 | 0 | 0.00 |
Zynex Inc Stock (ZYXI) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2025-03-12 | ダウングレード | Ladenburg Thalmann | Buy → Neutral |
2025-03-12 | ダウングレード | RBC Capital Mkts | Outperform → Sector Perform |
2023-10-16 | 開始されました | RBC Capital Mkts | Outperform |
2023-01-06 | アップグレード | Piper Sandler | Neutral → Overweight |
2022-02-28 | 繰り返されました | B. Riley Securities | Buy |
2021-07-16 | アップグレード | B. Riley Securities | Neutral → Buy |
2021-03-09 | アップグレード | Northland Capital | Market Perform → Outperform |
2021-02-26 | ダウングレード | B. Riley Securities | Buy → Neutral |
2021-01-29 | ダウングレード | Piper Sandler | Overweight → Neutral |
2021-01-28 | ダウングレード | Northland Capital | Outperform → Market Perform |
2020-09-14 | アップグレード | H.C. Wainwright | Neutral → Buy |
2020-09-09 | アップグレード | Northland Capital | Market Perform → Outperform |
2020-07-29 | アップグレード | B. Riley FBR | Neutral → Buy |
2020-07-20 | 開始されました | Piper Sandler | Overweight |
2020-07-13 | ダウングレード | B. Riley FBR | Buy → Neutral |
2020-07-10 | 繰り返されました | H.C. Wainwright | Neutral |
2020-06-16 | ダウングレード | Northland Capital | Outperform → Market Perform |
2020-05-19 | ダウングレード | H.C. Wainwright | Buy → Neutral |
2020-04-01 | 開始されました | Northland Capital | Outperform |
2019-09-23 | 開始されました | H.C. Wainwright | Buy |
すべてを表示
Zynex Inc (ZYXI) 最新ニュース
Royal Bank Of Canada Issues Pessimistic Forecast for Zynex (NASDAQ:ZYXI) Stock Price - MarketBeat
Zynex stock price target lowered to $3 by RBC amid payment issues - Investing.com Nigeria
Zynex (ZYXI) Target Price Lowered by RBC Capital, Maintains Rati - GuruFocus
RBC Capital Downgrades Zynex to Sector Perform, PT to $3 from $4. - AInvest
RBC Cuts Price Target on Zynex to $3 From $4, Keeps Sector Perform Rating - MarketScreener
Zynex: New CEO Steven Dyson shares his vision – ICYMI - Proactive financial news
Zynex, Inc. (ZYXI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Execs Of Device Co. Made $6M From Insider Trading, Suit Says - Law360
ZYNEX ALERT: Bragar Eagel & Squire, P.C. is Investigating - GlobeNewswire
Zynex Shareholder Sues Board, Execs Over Insurer’s Payment Pause - Bloomberg Law News
Zynex names Steven Dyson new CEO - ColoradoBiz
Zynex appoints Steven Dyson as CEO; founder Thomas Sandgaard moves to Chairman role to steer vision - Proactive financial news
Zynex CEO Thomas Sandgaard discusses leadership transitionICYMI - Proactive financial news
Zynex confirms continued temporary payment suspension from Tricare - Proactive financial news
Zynex Faces Continued Payment Suspension from Tricare - The Globe and Mail
Zynex Says Tricare Payment Suspension Will Continue Amid Review - MarketScreener
Zynex stock falls after Tricare extends payment suspension - Investing.com
Zynex stock falls after Tricare extends payment suspension By Investing.com - Investing.com India
Zynex, Inc. (ZYXI): Can Strategic Shifts and Liquidity Maneuvers Turn the Tide on Tricare's Stranglehold? - AInvest
Tricare Temporary Payment Suspension Update - PR Newswire
Medtech firm replacing CEO as it grapples with revenue loss, legal challenges - The Business Journals
Zynex appoints Steven Dyson as CEO, founder Thomas Sandgaard transitions to Chairman role - Proactive financial news
Zynex Appoints Steven Dyson as New CEO - TipRanks
H.C. Wainwright reiterates Buy rating on Zynex stock with $8 price target - Investing.com India
Zynex appoints Steven Dyson as new CEO effective August 18 By Investing.com - Investing.com Canada
Zynex Announces Steven Dyson as New CEO - GuruFocus
Zynex taps Steve Dyson as chief executive officer - Proactive financial news
Zynex, Inc.(NasdaqGS: ZYXI) dropped from Russell Small Cap Comp Growth Index - MarketScreener
Zynex Announces Steven Dyson as New CEO | ZYXI Stock News - GuruFocus
Small cap wrap: Medicus Pharma, Zynex, Liberty Star, First Phosphate... - Proactive Investors
Zynex secures UK patent for noninvasive sepsis monitoring device - Investing.com
Zynex Announces Award of UK Patent for Non-Invasive Detection of Sepsis - PR Newswire
Zynex awarded UK patent for non-invasive sepsis monitoring technology | NASDAQ:ZYXI - Proactive financial news
Zynex secures UK patent for noninvasive sepsis monitoring device By Investing.com - Investing.com Nigeria
Zynex Announces Workforce Reduction for Cost Savings - TipRanks
Zynex announces workforce reduction and provides update on Tricare payment suspension - Investing.com Canada
Zynex, Inc Founder and CEO Thomas Sandgaard to participate in Benzinga's Pharma Companies vs. A Tough Macro Backdrop Free Webinar on August 3rd at 12:15 PM ET - The Globe and Mail
Two Sigma Advisers LP Sells 5,000 Shares of Zynex, Inc. (NASDAQ:ZYXI) - Defense World
Zynex, Inc.'s (NASDAQ:ZYXI) Shares Bounce 41% But Its Business Still Trails The Industry - simplywall.st
Zynex, Inc. (NASDAQ:ZYXI) Shares Sold by BNP Paribas Financial Markets - Defense World
Zynex (NASDAQ:ZYXI) Stock Price Down 3.9% – What’s Next? - Defense World
Investigation announced for Long-Term Investors in shares of Zynex, Inc. (NASDAQ: ZYXI) over potential Wrongdoing - openPR.com
ZYXI LAWSUIT ALERT: The Gross Law Firm Notifies Zynex, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - cnhinews.com
Zynex submits NiCO pulse oximeter technology for FDA clearanceICYMI - Proactive financial news
Here’s Why Zynex (ZYXI) Fell in Q1 - Insider Monkey
Zynex submits FDA application for NiCO, a breakthrough non-invasive co-oximeter - Proactive financial news
Zynex, Inc. Investors: Please contact the Portnoy Law Firm - GlobeNewswire
Zynex, Inc. Investors: Please contact the Portnoy Law Firm to recover your losses; May 19, 2025 Deadline to file Lead Plaintiff Motion - GlobeNewswire Inc.
ZYXI Deadline: ZYXI Investors with Losses in Excess of $100K Have Opportunity to Lead Zynex, Inc. Securities Fraud Lawsuit - marketscreener.com
May 19, 2025 Deadline: Join Class Action Lawsuit Against Zynex, Inc. (ZYXI)Contact Levi & Korsinsky - ACCESS Newswire
ZYXI DEADLINE: ROSEN, LEADING TRIAL ATTORNEYS, Encourages - GlobeNewswire
Zynex Inc (ZYXI) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):